Ann: Quarterly Report and Appendix 4C, page-17

you need to educate yourself on the difference between a company that is in the Development Stage of their cycle like NTI who is being graded on significant development stage milestone results like their impending full double blind study. Compare that to NUH which is now being graded on production stage outputs (receipts). Because the NUH receipt level was underwhelming in consideration to where they are in their cycle (production stage) the share price is now going down.

Whilst NTI has major development stage milestones impending (full results/ FDA) they will be graded on achieving those milestones.